With 0.85 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.4 million shares. During the session, the Banks – Regional company that operates in wider Financial sector, reached to the highest price of $64.99 whereas the lowest price it dropped to was $62.03. The 52-week range on BMA shows that it touched its highest point at $64.37 and its lowest point at $15.17 during that stretch. It currently has a 1-year price target of $74.35. With its current market cap of 3.98 billion, BMA has annualized dividend of $0.00 while the current yield stands at 0.00%. Beta for the stock currently stands at 2.06.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BMA was up-trending over the past week, with a rise of 17.12%, but this was up by 24.20% over a month. Three-month performance surged to 95.71% while six-month performance rose 217.24%. The stock gained 299.58% in the past year, while it has gained 126.05% so far this year. A look at the trailing 12-month EPS for BMA yields 22.12 with Next year EPS estimates of 11.39. For the next quarter, that number is 2.15. This implies an EPS growth rate of -17.76% for this year and 27.05% for next year. EPS is expected to grow by 24.74% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 29.81%.
Float and Shares Shorts:
At present, 62.82 million BMA shares are outstanding with a float of 62.81 million shares on hand for trading. On 2024-04-15, short shares totaled 0.95 million, which was 117.0 higher than short shares on 1710460800. In addition to Mr. Gustavo Alejandro Manriquez as the firm’s GM & CEO, Mr. Jorge Francisco Scarinci serves as its CFO, Finance Manager & IR Manager.
Institutional Ownership:
Through their ownership of 0.05499 of BMA’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BMA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
